Association between Influenza Vaccine Administration and Primary Care Consultations for Respiratory Infections: Sentinel Network Study of Five Seasons (2014/2015-2018/2019) in the UK
- PMID: 33435229
- PMCID: PMC7827078
- DOI: 10.3390/ijerph18020523
Association between Influenza Vaccine Administration and Primary Care Consultations for Respiratory Infections: Sentinel Network Study of Five Seasons (2014/2015-2018/2019) in the UK
Abstract
Influenza, a vaccine preventable disease, is a serious global public health concern which results in a considerable burden on the healthcare system. However, vaccine hesitancy is increasingly becoming a global problem. One prevalent misconception is that influenza vaccinations can cause the flu. We carried out this study to determine whether people undertaking influenza vaccination presented less with acute respiratory tract infection (ARTI) and influenza-like-illness (ILI) following vaccination. We utilised the Oxford Royal College of General Practitioners Research and Surveillance Centre sentinel database to examine English patients who received vaccination between 2014/2015 and 2018/2019. Of the 3,841,700 influenza vaccinations identified, vaccination details and primary care respiratory consultation counts were extracted to calculate the relative incidence (RI) per exposure risk period using the self-controlled case series methodology. Results showed a significant increase in the RI of respiratory consultation rates within fourteen days of vaccination across all five years. Less than 6.2% of vaccinations led to consultations for ARTI or ILI in primary care (crude consultation rate 6196 per 100,000). These findings, particularly if confirmed in further research, may reduce the risk of cross-infection between waiting patients and increase uptake of influenza vaccine.
Keywords: general practice; influenza vaccine; primary care; vaccine hesitancy.
Conflict of interest statement
Simon de Lusignan is the Director of the RCGP RSC and has received funding through his University for studies from Eli Lilly, AstraZeneca, Sanofi, GSK, Seqirus, and Takeda; he has also been a member of advisory boards for influenza for Seqirus and Sanofi. These funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
Similar articles
-
Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age.Health Technol Assess. 2003;7(24):iii-x, 1-65. doi: 10.3310/hta7240. Health Technol Assess. 2003. PMID: 14499051 Clinical Trial.
-
Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010-2018).Vaccine. 2020 May 8;38(22):3869-3880. doi: 10.1016/j.vaccine.2020.03.034. Epub 2020 Apr 13. Vaccine. 2020. PMID: 32299719
-
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024.JMIR Public Health Surveill. 2024 Apr 3;10:e52047. doi: 10.2196/52047. JMIR Public Health Surveill. 2024. PMID: 38569175 Free PMC article.
-
Adverse Events of Interest Following Influenza Vaccination in the First Season of Adjuvanted Trivalent Immunization: Retrospective Cohort Study.JMIR Public Health Surveill. 2022 Mar 28;8(3):e25803. doi: 10.2196/25803. JMIR Public Health Surveill. 2022. PMID: 35343907 Free PMC article.
-
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment.Expert Rev Vaccines. 2024 Jan-Dec;23(1):1052-1067. doi: 10.1080/14760584.2024.2428243. Epub 2024 Nov 17. Expert Rev Vaccines. 2024. PMID: 39540854 Review.
References
-
- World Health Organization Influenza (Seasonal) [(accessed on 1 July 2020)]; Available online: https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)
-
- Iuliano A.D., Roguski K.M., Chang H.H., Muscatello D.J., Palekar R., Tempia S., Cohen C., Gran J.M., Schanzer D., Cowling B.J., et al. Estimates of global seasonal influenza-associated respiratory mortality: A modelling study. Lancet. 2018;391:1285–1300. doi: 10.1016/S0140-6736(17)33293-2. - DOI - PMC - PubMed
-
- Wang X., Li Y., O’Brien K.L., Madhi S.A., Widdowson M.A., Byass P., Omer S.B., Abbas Q., Ali A., Amu A., et al. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: A systematic review and modelling study. Lancet Glob. Health. 2020;8:e497–e510. doi: 10.1016/S2214-109X(19)30545-5. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical